Phytotherapy, biodiversity and public health
Connecting Brazil's natural heritage, science and new therapeutic routes.
“How do you scale AI in sectors where data is sensitive, regulated and cannot be shared?”
This is today the main bottleneck for unlocking innovation in healthcare and pharma, with direct impact on human health. The ConvergeLab Summit connects science, regulation and market around a shared agenda.
Each track is a research, regulatory and business agenda. Decision-makers, researchers and investors share the same space, for the first time in Brazil.
Connecting Brazil's natural heritage, science and new therapeutic routes.
How public systems can catalyze regulated innovation at scale.
AI, clinical data and infrastructure for a digital public health system.
Industrial sovereignty, the healthcare economic complex and regional RTOs.
BNDES, Finep, FAPs, venture capital and shared-risk models.
ANVISA, Conitec, LGPD, intellectual property and regulatory AI.
A high-level program on federated infrastructure, AI for the pharmaceutical industry and new models of collaboration across science, business and regulation.
What has already been done and learnt internationally.
How to turn industry pain points into structured opportunities for collaboration.
Showing concretely what start-ups and technology partners can deliver.
How to let algorithms learn from sensitive scientific and industrial data without requiring it to be centralised.
Leaders connecting digital health, scientific infrastructure, artificial intelligence and pharmaceutical innovation.
Suggest a speaker
Technical Advisor · Digital health and policy
A public-health and digital-transformation specialist with international experience in citizen-centred public systems.
An MSc graduate in Public Health from the London School of Hygiene and Tropical Medicine, he works across public health, migration and digital transformation. After roles in Mozambique, Peru, Kenya and Germany, he is now a Technical Advisor to GIZ’s German–Brazilian Digital Dialogue in Brasília, covering digital health, digital public infrastructure, emerging technologies and information integrity.
Director, Digital Engineering Division
He leads the strategy for digital technologies that create industrial value at Fraunhofer IPK.
Dr. Kai Lindow is an expert in digital technologies with a focus on data and model integration, digital ecosystems, data spaces and AI-driven solutions – always with an eye on business potential. For over a decade, he has been developing systemic approaches to make products and processes more efficient and resource-saving. After studying mechanical engineering in Berlin and Stockholm, he completed his PhD on “Knowledge-based development of sustainable products” at TU Berlin. Following his post-doctoral research at the interface of engineering and computer science, he became head of the Information and Process Control department at Fraunhofer IPK in Berlin, where he now serves as Director of Digital Engineering. He is actively involved in industrial and scientific working groups and a frequent voice on industry and research panels.
Head of the Soft and Biological Matter Division
He develops advanced synchrotron-light techniques to investigate high-resolution phenomena at the nano–bio interface.
At Sirius, he leads the development and application of synchrotron-light techniques for nanomedicine, nanotoxicology, health and environmental research. His strategic work spans the Sibipiruna, Timbó and Hibisco beamlines, integrated into Project Orion and high-containment environments for the safe study of complex biological systems.
Founder & Chief Technology Officer
A Medicinal Chemistry PhD with more than a decade of work in AI, predictive modelling and regulatory toxicology.
He has over ten years of experience in predictive modelling, analytics and data science for pharmaceutical innovation and regulatory toxicology. He is founder and CTO of NanoBusiness and InsilicAll, a Latin American platform combining artificial intelligence and computational methods to accelerate small molecules, protein therapeutics and toxicological safety assessments.
Chief Executive Officer
An R&D executive with 18 years of experience across the pharmaceutical and chemical industries.
A chemistry professional with 18 years of experience in Research, Development and Innovation. He has led multidisciplinary technical teams, new-product development and global strategic projects. As CEO of InsilicAll, he drives the company’s growth and international expansion by connecting deep chemistry expertise with artificial intelligence.
Founder & Principal Investigator
For more than 20 years he has turned nanotechnology, biotechnology and AI into pharmaceutical solutions and deep-tech ventures.
He has over 20 years of experience in research, development and innovation focused on advanced materials and pharmaceutical solutions. He is founder and Principal Investigator at NanoBusiness and ConvergeLab Venture Builder, de-risking deep-tech opportunities for investors, researcher-entrepreneurs and startups. He also teaches Innovation and Entrepreneurship at UFRJ.
Co-founder & Chief Scientific Officer
A theoretical chemist with a track record at Amgen, Pfizer and Aché, now leading Nintx.
He received his PhD in Theoretical and Organic Chemistry from the Federal University of Rio de Janeiro in 2001, followed by a postdoctorate with Prof. William Jorgensen at Yale University. He worked at Amgen and then Pfizer, both in the US, as a Senior Principal Scientist. In 2014 he returned to Brazil to lead the Radical Innovation Unit at Aché Laboratórios Farmacêuticos, focused on the discovery and early development of new chemical entities from synthetic and natural sources, and was promoted to Senior Director, Research, Innovation & New Technologies in 2020. He left Aché to start, with Dr. Miller Freitas and Mr. Stephani Saverio, a Brazilian company called Nintx (Next Innovative Therapeutics), which draws on intra- and interspecies biology and derived natural products to generate novel human therapies. He is the author of some 70 publications and patents.
Sales & Government Relations · Latin America
A scientist trained at USP and Uppsala, she leads ACS sales and government relations across Latin America.
She started as a scientist at USP, then completed a PhD and postdoc at Uppsala University in Sweden. She quickly realised her strength lay not only in generating knowledge but in connecting it: ideas with action, science with decision-making, people with purpose. That belief led her from academia into industry, first pharma and then scientific information and data. For over a decade she has been with the American Chemical Society, where she currently leads Sales and Government Relations for Latin America, doubling and tripling key contracts, negotiating multimillion-dollar agreements and deepening institutional partnerships across Brazil and the region. She advocates for gender equity in STEM and scientific capacity building in the Global South.
Executive Director · Head of Analytics & AI
A UFRJ PhD with a postdoc at ETH-Zürich, applying data science to R&D and operations.
Head of Data Analytics & Artificial Intelligence at Peers, he holds a PhD in Sciences from UFRJ and a postdoctoral degree in Computer Simulation from ETH-Zürich, Switzerland. He has been involved in computational research for over 15 years and has published more than 70 international scientific articles, and has been invited to speak in several countries. An entrepreneur, he founded and served as CEO of a data science startup. He has worked on projects with renowned companies in Brazil and abroad, mainly applying data science to R&D, supply chain, customer success and business expansion.
Chief Executive Officer
An entrepreneur with a track record leading fintech and healthtech companies across Europe and the Americas.
An experienced entrepreneur and startup executive with a strong international network and a solid track record leading fintech and healthtech companies across Europe and the Americas. He is currently the CEO of Open Health Technologies. He studied Business Informatics and IT Management in Berlin and London. Beyond his professional activities, he has a strong interest in biohacking, self-improvement and sports.
President, Brazil
President of Equinix in Brazil and a leading figure in Latin American digital infrastructure.
President of Equinix in Brazil and one of the leading figures in Latin America’s digital infrastructure sector. With more than 20 years at the company, he has built a career marked by strategic vision, deep technical knowledge and a central role in the country’s digital transformation. In his current position he leads Equinix’s expansion in Brazil, with billions of reais invested in recent years, consolidating the country as a regional hub for interconnection, cloud and AI. He also sits on the board of the Equinix Foundation and the Advisory Board of Escola da Nuvem, reaffirming his commitment to social responsibility and technology’s positive impact on society.
Senior Manager · AI Infrastructure Managed Services
He leads technical development of Equinix’s IaaS and Private AI platforms.
Senior Manager, AI Infrastructure Managed Services Solution Development at Equinix, where for more than 14 years he has built and operated the services underpinning the company’s global Managed Services operation. He currently leads the technical development of the platforms behind Equinix’s IaaS and Private AI portfolio, including NVIDIA DGX SuperPOD and Dell AI Factory solutions, running across AMER, EMEA and APAC. He is NVIDIA Certified in AI Infrastructure and Operations, an alumnus of Wharton’s Leading an AI-Powered Future programme and holds an Executive MBA in Entrepreneurship and New Business Development from FGV. He writes and speaks about the economics of AI infrastructure in production.
Pharmacist · Medical Affairs Section
A pharmacist working across public health policy, pharmacoeconomics and health technology assessment.
She works in innovation at Bio-Manguinhos/Fiocruz, in the Medical Affairs department. Her research covers public health policy, pharmacoeconomics and health technology assessment (HTA), aimed at optimising the use of resources and ensuring the sustainability of Brazil’s public health system. She coordinates the Technical Group of Pharmacists for Racial Equality at CRF/RJ. She has experience as a hospital pharmacist at Hospital Pró-Cardíaco and in primary care within the public health system. Between 2019 and 2024 she was a partner and manager of the independent cultural centre MOTIM, responsible for financial management and strategic planning.
Director
Former IBM Research leader, now heading the PUC-Behring Institute for Artificial Intelligence.
Director of the PUC-Behring Institute for Artificial Intelligence at the Pontifical Catholic University of Rio de Janeiro, with a career spanning artificial intelligence, decision-making and knowledge management. From 2011 to 2025 he was a Senior Research Manager at IBM Research, where he helped create the company’s research lab in Brazil and led AI initiatives in oil and gas, sustainable materials, mining, agriculture and finance. In 2026 he returned to PUC-Rio’s Department of Informatics as a professor. He holds a degree in Computer Engineering from PUC-Rio, a master’s and PhD in Informatics from the same university, and a postdoctorate from the University of Illinois Urbana-Champaign. At the Summit he presents the talk “Governable AI for Applied Discovery”.
Scientific Advisor to the Director
Bioinformatics and molecular modelling applied to finding new targets and drug candidates.
Scientific Advisor at the Brazilian Biosciences National Laboratory (LNBio/CNPEM) and a researcher in bioinformatics, molecular modelling and computational biology. He is an Associate Professor at the Biotechnology Center of UFRGS, with a degree in Pharmacy, a master’s in Pharmaceutical Sciences and a PhD in Cellular and Molecular Biology. His research focuses on the structure and dynamics of biomolecules, with special emphasis on glycans and glycoproteins, on building software and tools for bioinformatics, and on the search for new therapeutic targets and drug candidates.
Epidemiologist
A physician-epidemiologist using routinely collected data to fight infectious disease.
An epidemiologist with a background in medicine and public health, she currently works on OpenSAFELY. She previously worked as an epidemiologist at Argentina’s Ministry of Health, contributing to national COVID-19 surveillance and vaccine monitoring strategies. Her interest lies in using routinely collected data to tackle infectious diseases and reduce health inequalities. She graduated in Medicine from the University of Buenos Aires, specialised in Epidemiology through the Argentine Ministry of Health’s training programme, and holds an MSc in Public Health for Development from the London School of Hygiene and Tropical Medicine.
Partner & Director
Turning scientific discoveries into biotech companies across Latin America.
Partner and Director at GRIDX, a venture capital firm and accelerator for biotech startups in Latin America. With more than 15 years at the intersection of innovation, agribusiness and sustainability, he has broad experience in the agricultural markets of Brazil and Argentina. An agronomist by training, he focuses on developing and scaling high-impact scientific solutions. At GRIDX he leads the process of turning scientific discoveries into biotech-based deep tech companies, connecting scientists, entrepreneurs and investors to drive the next generation of food, health and environmental sustainability in the region.
Innovation Consultant · Advisor to FAPERJ’s Technology Board
A specialist in innovation ecosystems and mission-oriented policy.
A specialist in innovation, entrepreneurship ecosystems and mission-oriented policy. He holds a bachelor’s degree and teaching licence in Social Sciences, and a master’s and PhD in Public Policy, Strategy and Development from the Federal University of Rio de Janeiro (UFRJ). With a track record linking science, technology and socio-economic impact, he advises FAPERJ’s Technology Board and is an Innovation Consultant at the ECOA Institute/PUC-Rio, bringing academia, the public sector and the market together.
Head of the Paineira Group
Leads LNLS’s X-ray diffraction group, covering Sirius’s PAINEIRA and JATOBÁ beamlines.
She holds a degree in Physics, a master’s in Applied Physics and a PhD in Materials Science and Engineering, all from the University of São Paulo, and completed two postdoctoral stays in Inorganic Chemistry at UNICAMP. She has worked at the Brazilian Synchrotron Light Laboratory (LNLS-CNPEM) since 2005. Today she is an LNLS researcher and coordinates PAINEIRA, the polycrystalline X-ray diffraction beamline at Sirius, Brazil’s fourth-generation synchrotron light source. She leads the LNLS XPD Group, which brings together the PAINEIRA and JATOBÁ teams, the latter being the pair distribution function (PDF) beamline. Her research covers heterogeneous catalysis and materials and devices for energy storage, with an emphasis on structure–function characterisation through in situ and operando experiments using synchrotron techniques.
Hospitality & Participant Experience Coordination
A biologist and chef bringing together science, food and social change.
A biologist from the Federal University of Rio de Janeiro (UFRJ), with a master’s in Science and Health Education and a PhD in Sciences with an emphasis on Microbiology. Her scientific career includes time at the Albert Einstein College of Medicine in New York and the Jenner Institute at the University of Oxford. Along the way, her work took on a new dimension by bringing science, food and social change closer together. She is a Living Food educator certified by Fiocruz, a chef trained at Le Cordon Bleu, holds training in Social Gastronomy from Gastromotiva, and works in functional gastronomy, food safety and healthy eating.
Government Relations Manager
Connects government, industry and innovation policy in life sciences between the UK and Brazil.
Specialist in institutional relations, public policy and government affairs, with solid experience in the life sciences sector. His work sits at the interface between government, industry and innovation policy, contributing to institutional dialogue and international cooperation in strategic areas for health. Working within the context of British cooperation in Brazil, he takes part in initiatives that strengthen the connections between the UK and Brazilian innovation ecosystems.
Adviser to the Technology Directorate
Runs the TECNOVA and Centelha calls at FAPERJ and mentors start-ups in Rio de Janeiro.
PhD and MSc in Business Administration. She is an adviser to FAPERJ’s Technology Directorate, where she manages the TECNOVA and Centelha funding calls, and a lecturer at UFRJ’s Caxias Campus in Product Engineering, Production Management and Business Administration. She also advises start-ups in programmes and incubators in Rio de Janeiro.
Head of Operations
Former head of Fraunhofer’s Brazil office, connecting applied research, technology and industry.
PhD in Engineering from the Technical University of Berlin and MSc from ITA, with more than 15 years of international experience in industrial innovation, Industry 4.0 and digital transformation. He was Director of the Fraunhofer Office in Brazil (2020–2024) and has worked at CNI, Vale and international organisations. He leads operations at Ceará Tech Park (SENAI/CE), is a postdoctoral researcher at ITA and founded Lean 4.0, connecting applied research, technology and industry.
Principal Innovation Solutions Consultant
Nearly 20 years in deep tech strategy and commercialisation across the UK, Brazil and the Middle East.
PhD from Birkbeck, University of London, with research on innovation intermediaries in emerging economies. He has nearly 20 years of international experience in strategy, innovation and the commercialisation of deep tech in the UK, Brazil and the Middle East. He is a Principal Innovation Solutions Consultant at Digital Catapult, where he develops programmes, strategic partnerships and initiatives to accelerate and grow technology businesses.
Director of the X-ray Analytical Unit
Specialist in X-ray powder diffraction and pharmaceutical polymorphism.
Specialist in crystallography and X-ray powder diffraction (XRPD), with experience in pharmaceutical polymorphism, quantitative phase analysis and amorphous materials. She has worked at Diamond Light Source and Excelsus Structural Solutions, applying advanced synchrotron, total scattering and PDF techniques. She is Director of the X-ray Analytical Unit at the Bragg Centre for Materials Research, University of Leeds, UK.
Director of Industrial Development, Technology and Innovation
ITA professor and former CEO of IPT, bringing together science, technology and industry.
PhD in Mechanical Engineering from UFSC, professor at ITA since 2004 and Director of Industrial Development, Technology and Innovation at CNI (National Confederation of Industry). He led the Fraunhofer Project Center at ITA, helped build the SENAI Innovation Institutes network and was CEO of IPT (2019–2021). He has more than 20 years of experience in applied research, innovation management and industrial policy, bringing together science, technology and industry.
Coordinator of the Artificial Intelligence Centre (CIAI)
Governance, evaluation and standardisation of trustworthy artificial intelligence systems.
Researcher and technology specialist working at the intersection of Artificial Intelligence, Digital Metrology, Trustworthy AI and Critical Infrastructure. He is Coordinator of the Inmetro Artificial Intelligence Centre (CIAI), with activities focused on AI governance, digital transformation, AI evaluation methods, standardisation initiatives and trustworthy AI ecosystems.
Senior Researcher
Researches the interplay between science, technology and society and what it asks of contemporary governance.
Calum Inverarity is a Senior Researcher with the Research & Development team at the Open Data Institute (ODI). His interests lie in the interplay between science, technology and society, and the questions this asks of contemporary governance. He has previously worked with think tanks and research institutes in the UK and Belgium focusing on international security, economic policy and conflict resolution. Some of his previous research has explored decision making within complex systems, the science-policy nexus, illiberal democracy and post-conflict constitutional reform. He received his MSc from the University of Amsterdam and completed his BA at the University of Leeds, having spent periods studying at the University of California, San Diego and the University of Ghana.
Subdirector General de Innovación y Soluciones Asistenciales
Over 25 years leading AI, Big Data and data governance projects in public health.
Physician, electronic engineer and industrial technical engineer. He holds postgraduate degrees in AI for the Public Sector (AI4Gov) and Health Innovation Management, and researches AI and the EHDS (European Health Data Space) applied to clinical trials. He has more than 25 years of experience leading AI, Big Data and data governance projects. He was head of the Information Systems and Data Analysis Area at Spain’s Ministry of Health and Deputy Director General at the Community of Madrid, where he led health data spaces.
Co-founder & Managing Partner
Turns R&D and innovation into competitive advantage and runs the Deep Tech Summit.
Co-founder and Managing Partner of Emerge, a leading Latin American consultancy for companies, investors and public institutions that need to turn R&D and innovation into competitive advantage. He works in strategic R&D consulting focused on frontier technologies and in qualified technology scouting, mapping start-ups, universities and research centres. He runs the Deep Tech Summit, the largest deep tech event in Latin America, with more than 2,500 participants among investors, start-ups and executives. A production engineer specialised in financial management, he is also a deep tech investor and CFO of Peptidus, a biotech developing an AI-driven drug discovery platform for therapeutic peptides in animal health.
Under-Secretary for Innovation and Productive Environments
Engineer with a PhD from MIT, connecting university, industry and government for innovation in Rio.
Metallurgical engineer from IME, with an MSc in Materials Science and a PhD from MIT (USA). He is Under-Secretary for Innovation and Productive Environments of the State of Rio de Janeiro and has been an Associate Professor at UFF since 1986. He led UFF’s Innovation Agency (AGIR) for nine years, expanding its innovation environments. He has 30 years of experience in the steel industry at CSN, ArcelorMittal and Votorantim, and was also a Director and Board Member of ABM.
Co-Founder & CEO
Pioneer in 3D-printed medicines and personalised medicine.
Co-Founder and CEO of FabRx (London, UK), a pioneering company in 3D-printed pharmaceuticals and medical devices. With over 15 years of experience in pharmaceutics, he is a leading researcher in personalised medicine and pharmaceutical 3D printing. Recognised as a Highly Cited Researcher by Web of Science since 2019, he is also an Honorary Lecturer at University College London (UCL) and a part-time lecturer at the University of Santiago de Compostela, Spain.
Confirmed speakers · updated October 19, 2026
Receive the complete Summit material (program, sponsorship profiles and matchmaking opportunities) directly in your inbox.